The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis

Published:2017-05 Issue: Volume:99 Page:27-36
ISSN:0378-5122
Container-title:Maturitas
language:en
Short-container-title:Maturitas

Author:

Anagnostis Panagiotis,Galanis Petros,Chatzistergiou Vasileia,Stevenson John C.,Godsland Ian F.,Lambrinoudaki Irene,Theodorou Mamas,Goulis Dimitrios G.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,General Biochemistry, Genetics and Molecular Biology

Reference75 articles.

1. Menopause and the risk of coronary heart disease in women;Colditz;N. Engl. J. Med.,1987

2. Menopause and risk of cardiovascular disease: the Framingham study;Kannel;Ann. Intern.Med.,1976

3. Effects of menopause, sex and age on lipids and high-density lipoprotein cholesterol subfractions;Anagnostis;Maturitas,2015

4. Effects of gender, age and menopausal status on serum apolipoprotein concentrations;Anagnostis;Clin. Endocrinol. (Oxf.),2016

5. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974 to 2000;Godsland;Fertil. Steril,2001

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individuelle Risikoeinschätzung in Diagnostik und Therapie: Kardiovaskuläre Erkrankungen in der Menopause;Deutsches Ärzteblatt Online;2024-09-20

2. Understanding the Role of Sex Hormones in Cardiovascular Kidney Metabolic Syndrome: Toward Personalized Therapeutic Approaches;Journal of Clinical Medicine;2024-07-25

3. Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review;Pharmaceuticals;2024-07-09

4. Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia;Bulletin of Reproductive Health;2024-06-18

5. LP(a): Structure, Genetics, Associated Cardiovascular Risk, and Emerging Therapeutics;Annual Review of Pharmacology and Toxicology;2024-01-23